Neurorubine

Thiamine Hydrochloride, the active ingredient in Neurorubine, is a vitamin supplement presented as an injectable solution for intra‑articular, intravenous, and peri‑articular use. It supplies essential B‑vitamins (thiamine, pyridoxine, cyanocobalamin) that act as co‑enzymes in carbohydrate metabolism and nerve function, supporting patients with vitamin deficiencies or metabolic stress.

GNH USA supplies Neurorubine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory documentation to facilitate import and distribution across EU and other markets.

Neurorubine provides B‑vitamin supplementation and is used in clinical situations where metabolic support or deficiency correction is required. - Vitamin B12 deficiency: helps restore normal red blood cell formation and neurological function. - Peripheral neuropathy: supports nerve health and may reduce symptoms associated with B‑vitamin insufficiency. - Post‑operative metabolic support: supplies essential co‑enzymes for energy metabolism during recovery. - Malabsorption syndromes: corrects deficiencies in patients with gastrointestinal conditions that limit vitamin absorption.

Neurorubine may be associated with a range of adverse reactions, most of which are mild and related to the injection process.

Common Side Effects: - Injection site pain or erythema: mild discomfort at the site of administration. - Transient flushing: brief warmth or redness, often self‑limiting. - Nausea or mild gastrointestinal upset. - Headache: occasional mild headache after dosing. - Dizziness: temporary light‑headedness.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Hypotension: sudden drop in blood pressure post‑injection. - Stevens‑Johnson syndrome: rare severe skin reaction. - Severe neuropathy worsening: unexpected increase in neuropathic symptoms. - Thromboembolic events: rare clot formation.

When using Neurorubine, several precautions should be observed to ensure safe administration. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Renal impairment: monitor renal function and adjust therapy as needed. - Known hypersensitivity: avoid administration in patients with documented allergy to any B‑vitamin component. - Concurrent high‑dose vitamin therapy: assess risk of peripheral neuropathy or other toxicity. - Aseptic technique: ensure sterile handling to prevent contamination during intra‑articular or intravenous injection. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Neurorubine can interact with certain medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Methotrexate: concurrent use may increase hematologic toxicity. - Phenobarbital: may accelerate the metabolism of B‑vitamins, reducing therapeutic effect.

Moderate Interactions (Monitor Closely): - Phenytoin: may lower pyridoxine levels, necessitating monitoring. - Oral contraceptives: high‑dose B‑vitamins may alter hormone metabolism. - Diuretics: may affect renal excretion of water‑soluble vitamins, requiring dosage review.